RICHARD RAINVILLE: Open Payments
NPI 1023507290 · PARK CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 75 payments from 12 companies in 2025. Trend: 2023 $146 · 2024 $216 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $377 |
| Axsome Therapeutics, Inc. | 7 | $252 |
| Teva Pharmaceuticals USA, Inc. | 12 | $168 |
| E.R. Squibb & Sons, L.L.C. | 13 | $145 |
| Alkermes, Inc. | 9 | $144 |
| Neurocrine BioSciences, Inc. | 6 | $136 |
| Janssen Pharmaceuticals, Inc | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $84 |
| Lundbeck LLC | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $31 |
Products named: VRAYLAR, Auvelity, AUSTEDO XR, COBENFY, INGREZZA, REXULTI, SPRAVATO, ARISTADA.
Industry payments across UT — which companies pay providers there.
